| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |